Clinical trial
New-onset Severe Headache After Covid-19 Vaccine
NCT05235776 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New-onset Severe Headache After Covid-19 Vaccine
- Lead sponsor
- Oslo University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2022
- Completion date
- December 31, 2023
- Enrollment
- 63 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.